Professional
Added to YB: 2025-12-03
Pitch date: 2025-09-30
HIK.L [bullish]
Hikma Pharmaceuticals PLC
-13.52%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.
Market Cap
GBP 4.6B
Pitch Price
GBP 17.38
Price Target
N/A
Dividend
4.08%
EV/EBITDA
7.61
P/E
12.33
EV/Sales
1.83
Sector
Pharmaceuticals
Category
value
Show full summary:
Vela International Fund New Position: Hikma Pharmaceuticals PLC
HIK.L (new position): UK-based specialty & generic pharma w/ contract manufacturing adding US capacity to help foreign cos avoid tariffs via domestic production. Thesis: margin recovery from recent capex programs + negative sentiment on injectables division creates opportunity.
Read full article (1 min)